Breaking News

Over a week ago Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
ABBV AbbVie $80.78 0.07 (0.09%) , ICPT Intercept $95.04 -9.71 (-9.27%) … 04:55 04/14/19 04/14 04:55 04/14/19 04:55 Conference/Events	European Association for the Study of the Liver to hold a meeting » EASL International Liver… EASL International Liver Congress 2019 will be held in Vienna, Austria on April 10-14. ABBV AbbVie $80.78 0.07 (0.09%) ICPT Intercept $95.04 -9.71 (-9.27%) VRTX Vertex $182.69 -2.4 (-1.30%) GILD Gilead $65.27 -1.04 (-1.57%) AGN Allergan $144.94 -0.08 (-0.06%) GNFT Genfit $24.84 -0.02 (-0.08%) ALNY Alnylam $89.78 1.68 (1.91%) APEN Apollo Endosurgery $3.43 -0.025 (-0.72%) BMY Bristol-Myers $45.58 -0.52 (-1.13%) CBAY CymaBay $12.50 -0.6 (-4.58%) CTSO CytoSorbents $7.16 -0.28 (-3.76%) EIGR Eiger BioPharmaceuticals $14.25 -0.04 (-0.28%) ENTA Enanta $92.32 0.42 (0.46%) NDRA ENDRA Life Sciences $1.51 (0.00%) IPSEY Ipsen $0.00 (0.00%) MYRG MYR Group $36.36 -0.14 (-0.38%) NVS Novartis $80.26 -1.615 (-1.97%) NVO Novo Nordisk $50.21 -0.74 (-1.45%) OSUR OraSure $10.12 -0.12 (-1.17%) SIEGY Siemens $0.00 (0.00%) JNJ Johnson & Johnson $136.00 0.72 (0.53%) SBPH Spring Bank Pharmaceuticals $9.54 -0.29 (-2.95%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	16 Apr 17 Apr 24 Apr 25 Apr 25 Apr 25 Apr 25 Apr 25 Apr 30 Apr 01 May 02 May 03 May 06 May 07 May 08 May 08 May 08 May 18 May 20 May 21 May 21 May 21 May 28 May 29 May 05 Jun 06 Aug 13 Nov
ABBV AbbVie $80.78 0.07 (0.09%) , ICPT Intercept $95.04 -9.71 (-9.27%) … 04:55 04/13/19 04/13 04:55 04/13/19 04:55 Conference/Events	European Association for the Study of the Liver to hold a meeting » EASL International Liver… EASL International Liver Congress 2019 will be held in Vienna, Austria on April 10-14. ABBV AbbVie $80.78 0.07 (0.09%) ICPT Intercept $95.04 -9.71 (-9.27%) VRTX Vertex $182.69 -2.4 (-1.30%) GILD Gilead $65.27 -1.04 (-1.57%) AGN Allergan $144.94 -0.08 (-0.06%) GNFT Genfit $24.84 -0.02 (-0.08%) ALNY Alnylam $89.78 1.68 (1.91%) APEN Apollo Endosurgery $3.43 -0.025 (-0.72%) BMY Bristol-Myers $45.58 -0.52 (-1.13%) CBAY CymaBay $12.50 -0.6 (-4.58%) CTSO CytoSorbents $7.16 -0.28 (-3.76%) EIGR Eiger BioPharmaceuticals $14.25 -0.04 (-0.28%) ENTA Enanta $92.32 0.42 (0.46%) NDRA ENDRA Life Sciences $1.51 (0.00%) IPSEY Ipsen $0.00 (0.00%) MYRG MYR Group $36.36 -0.14 (-0.38%) NVS Novartis $80.26 -1.615 (-1.97%) NVO Novo Nordisk $50.21 -0.74 (-1.45%) OSUR OraSure $10.12 -0.12 (-1.17%) SIEGY Siemens $0.00 (0.00%) JNJ Johnson & Johnson $136.00 0.72 (0.53%) SBPH Spring Bank Pharmaceuticals $9.54 -0.29 (-2.95%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	13 Apr 16 Apr 17 Apr 24 Apr 25 Apr 25 Apr 25 Apr 25 Apr 25 Apr 30 Apr 01 May 02 May 03 May 06 May 07 May 08 May 08 May 08 May 18 May 20 May 21 May 21 May 21 May 28 May 29 May 05 Jun 06 Aug 13 Nov
ABBV AbbVie $81.78 -1.17 (-1.41%) , ICPT Intercept $104.75 -15.78 (-13.09%) … 04:55 04/12/19 04/12 04:55 04/12/19 04:55 Conference/Events	European Association for the Study of the Liver to hold a meeting » EASL International Liver… EASL International Liver Congress 2019 will be held in Vienna, Austria on April 10-14. ABBV AbbVie $81.78 -1.17 (-1.41%) ICPT Intercept $104.75 -15.78 (-13.09%) VRTX Vertex $185.09 -5.27 (-2.77%) GILD Gilead $66.31 -1.1 (-1.63%) AGN Allergan $145.02 -1.13 (-0.77%) GNFT Genfit $24.86 -0.27 (-1.07%) ALNY Alnylam $88.10 -2.74 (-3.02%) APEN Apollo Endosurgery $3.46 (0.00%) BMY Bristol-Myers $46.10 0.21 (0.46%) CBAY CymaBay $13.10 -0.05 (-0.38%) CTSO CytoSorbents $7.44 0.09 (1.22%) EIGR Eiger BioPharmaceuticals $14.29 -0.28 (-1.92%) ENTA Enanta $91.90 -2.85 (-3.01%) NDRA ENDRA Life Sciences $1.51 -0.01 (-0.66%) IPSEY Ipsen $0.00 (0.00%) MYRG MYR Group $36.50 0.24 (0.66%) NVS Novartis $81.87 -0.04 (-0.05%) NVO Novo Nordisk $50.95 -0.2 (-0.39%) OSUR OraSure $10.24 -0.14 (-1.35%) SIEGY Siemens $0.00 (0.00%) JNJ Johnson & Johnson $135.28 -0.33 (-0.24%) SBPH Spring Bank Pharmaceuticals $9.83 -0.06 (-0.61%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Apr 13 Apr 16 Apr 17 Apr 24 Apr 25 Apr 25 Apr 25 Apr 25 Apr 25 Apr 01 May 02 May 03 May 06 May 07 May 08 May 08 May 18 May 20 May 21 May 21 May 21 May 28 May 05 Jun 13 Nov
ABBV AbbVie $82.95 0.27 (0.33%) , ICPT Intercept $120.53 2.18 (1.84%) … 04:55 04/11/19 04/11 04:55 04/11/19 04:55 Conference/Events	European Association for the Study of the Liver to hold a meeting » EASL International Liver… EASL International Liver Congress 2019 will be held in Vienna, Austria on April 10-14. ABBV AbbVie $82.95 0.27 (0.33%) ICPT Intercept $120.53 2.18 (1.84%) VRTX Vertex $190.36 2.06 (1.09%) GILD Gilead $67.41 1.32 (2.00%) AGN Allergan $146.15 -1.3 (-0.88%) GNFT Genfit $25.13 -0.3 (-1.18%) ALNY Alnylam $90.84 2.07 (2.33%) APEN Apollo Endosurgery $3.46 0.175 (5.34%) BMY Bristol-Myers $45.89 -0.1 (-0.22%) CBAY CymaBay $13.15 0.21 (1.62%) CTSO CytoSorbents $7.35 -0.17 (-2.26%) EIGR Eiger BioPharmaceuticals $14.57 -0.31 (-2.08%) ENTA Enanta $94.75 2.28 (2.47%) NDRA ENDRA Life Sciences $1.52 -0.05 (-3.18%) IPSEY Ipsen $0.00 (0.00%) MYRG MYR Group $36.26 0.66 (1.85%) NVS Novartis $81.91 -1.49 (-1.79%) NVO Novo Nordisk $51.15 -0.005 (-0.01%) OSUR OraSure $10.38 -0.19 (-1.80%) SIEGY Siemens $0.00 (0.00%) JNJ Johnson & Johnson $135.61 -0.01 (-0.01%) SBPH Spring Bank Pharmaceuticals $9.89 -0.06 (-0.60%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	11 Apr 12 Apr 13 Apr 16 Apr 17 Apr 24 Apr 25 Apr 25 Apr 25 Apr 25 Apr 25 Apr 01 May 02 May 03 May 06 May 07 May 08 May 08 May 18 May 20 May 21 May 21 May 21 May 28 May 05 Jun 13 Nov
ABBV AbbVie $82.68 -1.3 (-1.55%) , ICPT Intercept $118.35 -1.84 (-1.53%) … 08:13 04/10/19 04/10 08:13 04/10/19 08:13 Conference/Events	European Association for the Study of the Liver to hold a meeting » EASL International Liver… EASL International Liver Congress 2019 will be held in Vienna, Austria on April 10-14. ABBV AbbVie $82.68 -1.3 (-1.55%) ICPT Intercept $118.35 -1.84 (-1.53%) VRTX Vertex $188.30 -0.63 (-0.33%) GILD Gilead $66.09 -1.28 (-1.90%) AGN Allergan $147.45 -3.04 (-2.02%) GNFT Genfit $25.43 -0.2 (-0.78%) ALNY Alnylam $88.77 -1.4 (-1.55%) APEN Apollo Endosurgery $3.28 (0.00%) BMY Bristol-Myers $45.99 -0.76 (-1.63%) CBAY CymaBay $12.94 -0.54 (-4.01%) CTSO CytoSorbents $7.52 0.02 (0.27%) EIGR Eiger BioPharmaceuticals $14.88 -0.08 (-0.53%) ENTA Enanta $92.47 0.03 (0.03%) NDRA ENDRA Life Sciences $1.57 0.02 (1.29%) IPSEY Ipsen $0.00 (0.00%) MYRG MYR Group $35.60 -0.37 (-1.03%) NVS Novartis $83.40 -11.515 (-12.13%) NVO Novo Nordisk $51.16 -0.205 (-0.40%) OSUR OraSure $10.57 -0.29 (-2.67%) SIEGY Siemens $0.00 (0.00%) JNJ Johnson & Johnson $135.62 -0.51 (-0.37%) SBPH Spring Bank Pharmaceuticals $9.95 -0.56 (-5.33%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	10 Apr 10 Apr 12 Apr 13 Apr 16 Apr 17 Apr 24 Apr 25 Apr 25 Apr 25 Apr 25 Apr 25 Apr 01 May 02 May 03 May 06 May 07 May 08 May 08 May 18 May 20 May 21 May 21 May 21 May 28 May 05 Jun 13 Nov

Over a month ago
APEN Apollo Endosurgery $3.29 -0.06 (-1.79%) 13:13 03/18/19 03/18 13:13 03/18/19 13:13 Recommendations	Apollo Endosurgery analyst commentary at Piper Jaffray » Piper says Apollo's… Piper says Apollo's OverStitch growth more important than balloon sales declines. Piper Jaffray analyst JP McKim noted that Apollo Endosurgery reported Q4 sales and gave 2019 guidance that were both relatively in-line with estimates, but he believes the fact that OverStitch sales outperformed expectations is more important than the decline in balloon sales. While the early feedback from the alpha launch was positive, McKim believes Apollo will need to show execution on SX sales before seeing its multiple expand. He keeps an Overweight rating and $5.50 price target on Apollo Endosurgery. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	18 Mar 18 May 28 May
APEN Apollo Endosurgery $3.35 (0.00%) 08:04 03/18/19 03/18 08:04 03/18/19 08:04 Earnings	Apollo Endosurgery reports Q4 EPS (84c), consensus (37c) » Reports Q4 revenue… Reports Q4 revenue $15.18M, consensus $14.96M. Todd Newton, CEO of Apollo, said, "With the sale of the Surgical product line in December, moving forward we are able to direct our attention exclusively on the growth opportunities of our Endo-bariatric product line. Demand for OverStitch was strong in the fourth quarter as the treatments possible with this unique technology continue to gain physician adoption and as of the beginning of February we are into the full launch of the new single channel compatible OverStitch Sx in the United States and Europe." 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	18 Mar 18 May 28 May

Over a quarter ago
OBLN Obalon Therapeutics $1.83 (0.00%) , APEN Apollo Endosurgery $3.28 -0.27 (-7.61%) 14:15 01/14/19 01/14 14:15 01/14/19 14:15 Conference/Events	Piper Jaffray medical devices analyst to hold analyst/industry conference call » Medical Devices Analyst… Medical Devices Analyst McKim, along with Key Opinion Leader Dr. Kumbhari, Bariatric Endoscopy Director at Johns Hopkins Medicine, provides an update on the bariatric market for various medical devices such as Apollo Endosurgery's (APEN) Orbera and Reshape systems vs. Obalon Therapeutics (OBLN) balloon system on an Analyst/Industry conference call to be held on January 14 at 3 pm. OBLN Obalon Therapeutics $1.83 (0.00%) APEN Apollo Endosurgery $3.28 -0.27 (-7.61%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	14 Jan 18 May
OBLN Obalon Therapeutics $1.82 -0.01 (-0.55%) , APEN Apollo Endosurgery $3.26 -0.29 (-8.17%) 10:43 01/14/19 01/14 10:43 01/14/19 10:43 Conference/Events	Piper Jaffray medical devices analyst to hold analyst/industry conference call » Medical Devices Analyst… Medical Devices Analyst McKim, along with Key Opinion Leader Dr. Kumbhari, Bariatric Endoscopy Director at Johns Hopkins Medicine, provides an update on the bariatric market for various medical devices such as Apollo Endosurgery's (APEN) Orbera and Reshape systems vs. Obalon Therapeutics (OBLN) balloon system on an Analyst/Industry conference call to be held on January 14 at 3 pm. OBLN Obalon Therapeutics $1.82 -0.01 (-0.55%) APEN Apollo Endosurgery $3.26 -0.29 (-8.17%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	18 May
APEN Apollo Endosurgery $3.45 -0.08 (-2.27%) 08:27 01/02/19 01/02 08:27 01/02/19 08:27 Upgrade	Apollo Endosurgery rating change at Northland » Apollo Endosurgery… Apollo Endosurgery upgraded to Market Perform from Underperform at Northland. Northland analyst Suraj Kalia upgraded Apollo Endosurgery to Market Perform and maintained a $3 price target citing valuation. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	18 May

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial